Jeeva Clinical Trials Inc.

Jeeva’s virtual control room empowers biopharma and medical device sponsors to manage end-to-end clinical trials with real-time monitoring, boosting efficiency, reducing risks, and cutting costs through a single login and subscription model. By streamlining trial logistics for both participants and study teams, Jeeva offers key features like bi-directional communications, eligibility screening, scheduling, electronic data capture (EDC), electronic clinical outcome assessments (eCOA), TeleVisits, and touchless remote eConsent.

Driven by AI, the Jeeva platform automates visit schedules and protocol configurations, seamlessly integrating modules such as eConsent, ePRO/eCOA/EDC, TeleVisits/VideoVisits, adverse event reporting with MedDRA coding, and a patient engagement portal that supports communication through SMS, email, audio, and video with reminders and notifications.

The personal experience of losing a child born with a rare disease and a brother with a chronic disease became the springboard for Dr. Harsha Rajasimha to apply his years of postdoctoral training at NIH and FDA to accelerate therapies for rare and common conditions. He knew that technology in itself is not the limiting factor and that patient-centered design guided by stakeholder needs and regulatory requirements would guide their continuous learning digital platform.

By digitizing and automating manual repetitive tasks and reducing the logistical burdens on patients and study teams by over 70%, Jeeva accelerates the process of bringing new medicines or vaccines to patients who need them by over 3x faster. The Virginia-based company’s modular software-as-a-service platform is fully scalable and facilitates diverse patient enrollment, engagement, and evidence generation in clinical trials on any browser-enabled mobile device.